Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Optimizing mouse models of neurodegenerative disorders: are therapeutics in sight?.

Future neurology

Lutz CM, Osborne MA.
PMID: 29479291
Future Neurol. 2013;9(1):67-75. doi: 10.2217/fnl.13.66. Epub 2013 Dec 16.

The genomic and biologic conservation between mice and humans, along with our increasing ability to manipulate the mouse genome, places the mouse as a premier model for deciphering disease mechanisms and testing potential new therapies. Despite these advantages, mouse...

Cite
Lutz CM, Osborne MA. Optimizing mouse models of neurodegenerative disorders: are therapeutics in sight?. Future Neurol. 2013;9(1):67-75doi: 10.2217/fnl.13.66.
Lutz, C. M., & Osborne, M. A. (2013). Optimizing mouse models of neurodegenerative disorders: are therapeutics in sight?. Future neurology, 9(1), 67-75. https://doi.org/10.2217/fnl.13.66
Lutz, Cathleen M, and Osborne, Melissa A. "Optimizing mouse models of neurodegenerative disorders: are therapeutics in sight?." Future neurology vol. 9,1 (2013): 67-75. doi: https://doi.org/10.2217/fnl.13.66
Lutz CM, Osborne MA. Optimizing mouse models of neurodegenerative disorders: are therapeutics in sight?. Future Neurol. 2013;9(1):67-75. doi: 10.2217/fnl.13.66. Epub 2013 Dec 16. PMID: 29479291; PMCID: PMC5822737.
Copy Download .nbib Format: NLM
Diabetes research in children network:availability of protocol data sets.

Journal of diabetes science and technology

Ruedy KJ, Beck RW, Xing D, Kollman C.
PMID: 18490965
J Diabetes Sci Technol. 2007 Sep;1(5):738-45. doi: 10.1177/193229680700100519.

The Diabetes Research in Children Network (DirecNet) was established in 2001 by the National Institute of Child Health and Human Development and the National Institute of Diabetes and Digestive and Kidney Diseases through special congressional funding for type 1...

Cite
Ruedy KJ, Beck RW, Xing D, et al. Diabetes research in children network:availability of protocol data sets. J Diabetes Sci Technol. 2007;1(5):738-45doi: 10.1177/193229680700100519.
Ruedy, K. J., Beck, R. W., Xing, D., & Kollman, C. (2007). Diabetes research in children network:availability of protocol data sets. Journal of diabetes science and technology, 1(5), 738-45. https://doi.org/10.1177/193229680700100519
Ruedy, Katrina J, et al. "Diabetes research in children network:availability of protocol data sets." Journal of diabetes science and technology vol. 1,5 (2007): 738-45. doi: https://doi.org/10.1177/193229680700100519
Ruedy KJ, Beck RW, Xing D, Kollman C. Diabetes research in children network:availability of protocol data sets. J Diabetes Sci Technol. 2007 Sep;1(5):738-45. doi: 10.1177/193229680700100519. PMID: 18490965; PMCID: PMC2387002.
Copy Download .nbib Format: NLM
Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis.

Metabolic syndrome and related disorders

Rosenkranz SL, Yarasheski KE, Para MF, Reichman RC, Morse GD.
PMID: 18007962
Metab Syndr Relat Disord. 2007 Jun;5(2):163-73. doi: 10.1089/met.2006.0034.

BACKGROUND: HIV-infected patients treated with antiretroviral medications (ARVs) develop undesirable changes in lipid and glucose metabolism that mimic the metabolic syndrome and may be proatherogenic. Antiretroviral drug levels and their interactions may contribute to these metabolic alterations.METHODS: Fifty six...

Cite
Rosenkranz SL, Yarasheski KE, Para MF, et al. Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis. Metab Syndr Relat Disord. 2007;5(2):163-73doi: 10.1089/met.2006.0034.
Rosenkranz, S. L., Yarasheski, K. E., Para, M. F., Reichman, R. C., & Morse, G. D. (2007). Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis. Metabolic syndrome and related disorders, 5(2), 163-73. https://doi.org/10.1089/met.2006.0034
Rosenkranz, Susan L, et al. "Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis." Metabolic syndrome and related disorders vol. 5,2 (2007): 163-73. doi: https://doi.org/10.1089/met.2006.0034
Rosenkranz SL, Yarasheski KE, Para MF, Reichman RC, Morse GD. Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis. Metab Syndr Relat Disord. 2007 Jun;5(2):163-73. doi: 10.1089/met.2006.0034. PMID: 18007962; PMCID: PMC2078603.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries